Trial intelligence / Profile preview

Pharmacokinetic study of progesterone and allopregnanolone in refractory epilepsy (Phase II)

TCTR20200710005Phase 2Completed

Sponsor
Silpakorn University
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of progesterone in epilepsy, sponsored by Silpakorn University. Started Jul 2020; status: completed.

02

Drugs

progesterone
03

Conditions

epilepsy

Beyond the preview

Go deeper on TCTR20200710005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200710005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call